Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8051 USD | +5.01% | +0.02% | -21.07% |
04-22 | Danimer Scientific Announces $20 Million Asset-Based Revolving Credit Facility | CI |
04-10 | North American Morning Briefing : Traders Await -2- | DJ |
Summary
- The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-21.07% | 91.98M | D | ||
+3.99% | 40.11B | B- | ||
-19.14% | 22.51B | B- | ||
-13.76% | 13.47B | B- | ||
-9.95% | 10.16B | B+ | ||
-10.19% | 9.64B | A- | ||
+14.74% | 7.55B | C+ | ||
+12.15% | 7B | C+ | ||
-26.77% | 5.56B | C | ||
-29.24% | 3.37B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DNMR Stock
- Ratings Danimer Scientific, Inc.